Anna Cebula
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
-
- Gut microbiota and health
Papers in
-
- T-cell and B-cell Immunology 8
- Psoriasis: Treatment and Pathogenesis 1
- IL-33, ST2, and ILC Pathways 1
-
- Epigenetics and DNA Methylation 1
- Gut microbiota and health 1
- Genomics and Chromatin Dynamics 1
- Co-authors
- Leszek Ignatowicz (9 shared papers)Gregorz A. Rempała (4 shared papers)Paweł Kisielow (3 shared papers)Casandra Panea (1 shared paper)Terri M. Laufer (1 shared paper)Ivaylo I. Ivanov (1 shared paper)Gaku Nakato (1 shared paper)Yoshiyuki Goto (1 shared paper)
- Journals
- Nature Communications (1 paper)Science Advances (1 paper)PLoS ONE (1 paper)Mucosal Immunology (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- United StatesPolandFrance
In The Last Decade
Anna Cebula
10 papers receiving 1k citations
Peers
Comparison fields: 5 of 63
- Immunology 566
- Molecular Biology 441
- Genetics 82
- Biological Psychiatry 3
- Rheumatology 28
Countries citing papers authored by Anna Cebula
This map shows the geographic impact of Anna Cebula's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Cebula with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Cebula more than expected).
Fields of papers citing papers by Anna Cebula
This network shows the impact of papers produced by Anna Cebula. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Cebula. The network helps show where Anna Cebula may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Cebula, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 400 | |
| 2 | 2013 | 334 | |
| 3 | 2015 | 135 | |
| 4 | 2020 | 61 | |
| 5 | 2010 | 29 | |
| 6 | 2020 | 29 | |
| 7 | 2019 | 26 | |
| 8 | 2008 | 16 | |
| 9 | 2018 | 10 | |
| 10 | 2026 | 1 |
About Anna Cebula
Anna Cebula is a scholar working on Immunology, Molecular Biology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 10 papers that have together received 1k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Epigenetics and DNA Methylation (1 paper), Psoriasis: Treatment and Pathogenesis (1 paper), Gut microbiota and health (1 paper), Genomics and Chromatin Dynamics (1 paper) and IL-33, ST2, and ILC Pathways (1 paper). The work is most often cited by research in Immunology (566 citations), Molecular Biology (441 citations), Genetics (82 citations), Biological Psychiatry (3 citations) and Rheumatology (28 citations). Anna Cebula has collaborated with scholars based in United States, Poland and France. Frequent co-authors include Leszek Ignatowicz, Gregorz A. Rempała, Paweł Kisielow, Casandra Panea, Terri M. Laufer, Ivaylo I. Ivanov, Gaku Nakato, Yoshiyuki Goto, Marta Galán-Díez and Piotr Jan Kraj. Their work appears in journals such as Nature Communications, Science Advances, PLoS ONE, Mucosal Immunology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.